Dr. Puzanov on Sequencing Targeted Therapy and Immunotherapy in Melanoma – OncLive
OncLive |
Dr. Puzanov on Sequencing Targeted Therapy and Immunotherapy in Melanoma
OncLive Igor Puzanov, MD, director, Early Phase Clinical Trials Program, chief of Melanoma, coleader, CCSG Experimental Therapeutics Program, professor of Oncology, Department of Medicine, Roswell Park Cancer Institute, discusses an ongoing study exploring … |
